Featured Posts

Tuesday, February 5, 2019

Therapeutics Granted Orphan Drug Designation by the FDA for Autoimmune Hepatitis

STOCKHOLM, Feb. 5, 2019 /PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the company for the treatment of Autoimmune hepatitis (AIH). More information about the ODD...

from PR Newswire: https://prn.to/2Gp4cGj

No comments:

Post a Comment